Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3510LO1M
Performance in the last:
Follow this Portfolio
1D 0.1 %
1W 1.5 %
2W 1.8 %
1M 3.3 %
3M 8.8 %
6M 5.7 %
9M 1.3 %
1Y 13.9 %
Alpha
-13.0%
Beta
0.77
sharpe-R
0.45
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
2.64
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2024-12-03 08:17:00
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -16.99%
Max. DrawDown Benchmark -8.41%

This Long Only strategy aims to find promising assets to invest in for a maximum holding period of 1 Month in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 10.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
3
Difficulty Level
2

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Action Weight PnL
ITGR Integer Holdings Corporation Buy 7.23% 1.47%
APLS Apellis Pharmaceuticals, Inc. Buy 10.47% 8.55%
MGNX MacroGenics, Inc. Buy 10.47% 8.53%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.58% 0.73%
ESPR Esperion Therapeutics, Inc. Buy 9.87% 0%
The percentage of cash held in the portfolio is: 51.37%
** The description of each asset is available Here

The latest 5 Compositions change

2024-12-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
ITGR Integer Holdings Corporation Buy 7.23% 1.47%
APLS Apellis Pharmaceuticals, Inc. Buy 10.47% 8.55%
MGNX MacroGenics, Inc. Buy 10.47% 8.53%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.58% 0.73%
ESPR Esperion Therapeutics, Inc. Buy 9.87% 0%
The percentage of cash held in the portfolio is: 51.37%
New Assets Added
  • ESPR
Assets Removed
Asset Action Perf %
FATE Sell All -6.62%
Assets Rebalanced
None
2024-11-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ITGR Integer Holdings Corporation Buy 7.32% 2.95%
APLS Apellis Pharmaceuticals, Inc. Buy 10.07% 4.63%
MGNX MacroGenics, Inc. Buy 10.31% 7.06%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.48% 0%
FATE Fate Therapeutics, Inc. Buy 10.48% 0%
The percentage of cash held in the portfolio is: 51.33%
New Assets Added
None
Assets Removed
Asset Action Perf %
NEOG Sell All NA
Assets Rebalanced
None
2024-11-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
NEOG Neogen Corporation Buy 7.41% -1.39%
ITGR Integer Holdings Corporation Buy 7.32% 2.95%
APLS Apellis Pharmaceuticals, Inc. Buy 10.07% 4.63%
MGNX MacroGenics, Inc. Buy 10.31% 7.06%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.48% 0%
FATE Fate Therapeutics, Inc. Buy 10.48% 0%
The percentage of cash held in the portfolio is: 43.92%
New Assets Added
  • ARWR
  • FATE
Assets Removed
Asset Action Perf %
HCSG Sell All 13.06%
Assets Rebalanced
None
2024-11-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 14.69% 10.78%
NEOG Neogen Corporation Buy 7.54% -1.19%
ITGR Integer Holdings Corporation Buy 7.33% 1.48%
APLS Apellis Pharmaceuticals, Inc. Buy 9.78% 0%
MGNX MacroGenics, Inc. Buy 9.78% 0%
The percentage of cash held in the portfolio is: 50.88%
New Assets Added
  • APLS
  • MGNX
Assets Removed
None
Assets Rebalanced
None
2024-11-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 14.17% 6.67%
NEOG Neogen Corporation Buy 7.98% 4.46%
ITGR Integer Holdings Corporation Buy 7.31% 0.99%
The percentage of cash held in the portfolio is: 70.54%
New Assets Added
None
Assets Removed
Asset Action Perf %
CDMO Sell All 18.73%
Assets Rebalanced
None
2024-11-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
CDMO Avid Bioservices, Inc. Buy 9.43% 17.66%
HCSG Healthcare Services Group, Inc. Buy 13.87% 3.74%
NEOG Neogen Corporation Buy 8.09% 5.23%
ITGR Integer Holdings Corporation Buy 7.11% -2.37%
The percentage of cash held in the portfolio is: 61.49%
New Assets Added
None
Assets Removed
Asset Action Perf %
MGNX Sell All -10.08%
MDRX Sell All -7.2%
Assets Rebalanced
None
2024-11-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
CDMO Avid Bioservices, Inc. Buy 9.36% 17.18%
HCSG Healthcare Services Group, Inc. Buy 14.05% 5.39%
NEOG Neogen Corporation Buy 7.8% 1.81%
MGNX MacroGenics, Inc. Buy 8.11% -7.75%
ITGR Integer Holdings Corporation Buy 7.07% -2.62%
MDRX Allscripts Healthcare Solutions, Inc. Buy 11.33% -5.24%
The percentage of cash held in the portfolio is: 42.28%
New Assets Added
None
Assets Removed
Asset Action Perf %
RGEN Sell All -17.11%
VREX Sell All 13.22%
Assets Rebalanced
None
2024-11-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 9.64% 12.89%
CDMO Avid Bioservices, Inc. Buy 9% 15.15%
HCSG Healthcare Services Group, Inc. Buy 14.2% 8.95%
NEOG Neogen Corporation Buy 7.65% 2.09%
MGNX MacroGenics, Inc. Buy 8.46% -1.55%
ITGR Integer Holdings Corporation Buy 7% -1.41%
MDRX Allscripts Healthcare Solutions, Inc. Buy 11.24% -3.91%
RGEN Repligen Corporation Buy 9.23% -5.34%
The percentage of cash held in the portfolio is: 23.59%
New Assets Added
None
Assets Removed
Asset Action Perf %
NUTX Sell All 26.23%
ALT Sell All -10.91%
Assets Rebalanced
None
2024-11-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 9.47% 15.04%
NUTX Nutex Health Inc. Buy 11.38% 31.39%
CDMO Avid Bioservices, Inc. Buy 8.88% 17.76%
HCSG Healthcare Services Group, Inc. Buy 14% 11.32%
NEOG Neogen Corporation Buy 7.65% 5.86%
MGNX MacroGenics, Inc. Buy 8.08% -2.58%
ITGR Integer Holdings Corporation Buy 6.89% 0.58%
MDRX Allscripts Healthcare Solutions, Inc. Buy 11.18% -0.89%
ALT Altimmune, Inc. Buy 11.07% 0.32%
RGEN Repligen Corporation Buy 9.41% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RGEN
Assets Removed
Asset Action Perf %
ARWR Sell All 11.73%
Assets Rebalanced
None
2024-11-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARWR Arrowhead Pharmaceuticals, Inc. Buy 9.03% 11.11%
VREX Varex Imaging Corporation Buy 9.46% 18.26%
NUTX Nutex Health Inc. Buy 12.74% 51.33%
CDMO Avid Bioservices, Inc. Buy 8.64% 18.05%
HCSG Healthcare Services Group, Inc. Buy 13.88% 13.61%
NEOG Neogen Corporation Buy 7.51% 6.97%
MGNX MacroGenics, Inc. Buy 8.53% 5.94%
ITGR Integer Holdings Corporation Buy 6.66% 0.1%
MDRX Allscripts Healthcare Solutions, Inc. Buy 10.83% -1.24%
ALT Altimmune, Inc. Buy 10.72% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ALT
Assets Removed
Asset Action Perf %
IOVA Sell All -12.15%
Assets Rebalanced
None
2024-11-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARWR Arrowhead Pharmaceuticals, Inc. Buy 9.29% 13.48%
VREX Varex Imaging Corporation Buy 9.73% 20.74%
NUTX Nutex Health Inc. Buy 9.53% 12.45%
CDMO Avid Bioservices, Inc. Buy 8.72% 18.24%
HCSG Healthcare Services Group, Inc. Buy 13.71% 11.51%
IOVA Iovance Biotherapeutics, Inc. Buy 11.87% -3.45%
NEOG Neogen Corporation Buy 8.09% 14.37%
MGNX MacroGenics, Inc. Buy 9.2% 13.44%
ITGR Integer Holdings Corporation Buy 6.83% 2%
MDRX Allscripts Healthcare Solutions, Inc. Buy 11.04% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MDRX
Assets Removed
Asset Action Perf %
VCEL Sell All 34.9%
Assets Rebalanced
None
2024-11-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARWR Arrowhead Pharmaceuticals, Inc. Buy 9.29% 13.07%
VCEL Vericel Corporation Buy 10.54% 28.3%
VREX Varex Imaging Corporation Buy 9.5% 17.52%
NUTX Nutex Health Inc. Buy 10.81% 27.16%
CDMO Avid Bioservices, Inc. Buy 8.75% 18.34%
HCSG Healthcare Services Group, Inc. Buy 13.38% 8.4%
IOVA Iovance Biotherapeutics, Inc. Buy 11.85% -3.99%
NEOG Neogen Corporation Buy 8.03% 13.18%
MGNX MacroGenics, Inc. Buy 9.14% 12.4%
ITGR Integer Holdings Corporation Buy 6.72% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ITGR
Assets Removed
Asset Action Perf %
ARDX Sell All -16.06%
Assets Rebalanced
None
2024-11-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.08% 0.83%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 9.07% 0.67%
VCEL Vericel Corporation Buy 9.41% 4.51%
VREX Varex Imaging Corporation Buy 9.67% 9.09%
NUTX Nutex Health Inc. Buy 8.49% -8.94%
CDMO Avid Bioservices, Inc. Buy 8.04% -0.87%
HCSG Healthcare Services Group, Inc. Buy 13.78% 1.83%
IOVA Iovance Biotherapeutics, Inc. Buy 13.72% 1.45%
NEOG Neogen Corporation Buy 7.83% 0.7%
MGNX MacroGenics, Inc. Buy 8.92% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MGNX
Assets Removed
Asset Action Perf %
IRWD Sell All -1.64%
Assets Rebalanced
None
2024-10-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 9.07% -0.23%
ARDX Ardelyx, Inc. Buy 8.98% -0.5%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 9.31% 3.2%
VCEL Vericel Corporation Buy 9.83% 8.89%
VREX Varex Imaging Corporation Buy 9.77% 10%
NUTX Nutex Health Inc. Buy 8.32% -10.96%
CDMO Avid Bioservices, Inc. Buy 7.99% -1.74%
HCSG Healthcare Services Group, Inc. Buy 13.65% 0.64%
IOVA Iovance Biotherapeutics, Inc. Buy 13.29% -1.99%
NEOG Neogen Corporation Buy 7.8% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NEOG
Assets Removed
Asset Action Perf %
NKTR Sell All -12.41%
Assets Rebalanced
None
2024-10-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 8.78% -2.58%
ARDX Ardelyx, Inc. Buy 8.73% -2.32%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 9.32% 4.24%
VCEL Vericel Corporation Buy 9.7% 8.48%
VREX Varex Imaging Corporation Buy 9.56% 8.68%
NKTR Nektar Therapeutics Buy 8.25% -6.21%
NUTX Nutex Health Inc. Buy 8.95% -3.3%
CDMO Avid Bioservices, Inc. Buy 7.85% -2.51%
HCSG Healthcare Services Group, Inc. Buy 13.43% 0%
IOVA Iovance Biotherapeutics, Inc. Buy 13.43% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HCSG
  • IOVA
Assets Removed
Asset Action Perf %
SGMO Sell All 110.31%
Assets Rebalanced
None
2024-10-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 8.95% -7.04%
ARDX Ardelyx, Inc. Buy 9.13% -4.47%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 9.92% 3.82%
VCEL Vericel Corporation Buy 9.93% 3.94%
SGMO Sangamo Therapeutics, Inc. Buy 14.76% 54.64%
VREX Varex Imaging Corporation Buy 10.03% 6.69%
NKTR Nektar Therapeutics Buy 8.56% -8.97%
NUTX Nutex Health Inc. Buy 9.68% -2.14%
CDMO Avid Bioservices, Inc. Buy 8.3% -3.47%
The percentage of cash held in the portfolio is: 10.76%
New Assets Added
None
Assets Removed
Asset Action Perf %
ORGO Sell All -9.09%
Assets Rebalanced
None
2024-10-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 8.95% -6.57%
ORGO Organogenesis Holdings Inc. Buy 8.99% -6.17%
ARDX Ardelyx, Inc. Buy 8.78% -7.62%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 9.78% 2.89%
VCEL Vericel Corporation Buy 9.55% 0.45%
SGMO Sangamo Therapeutics, Inc. Buy 15.08% 58.76%
VREX Varex Imaging Corporation Buy 9.86% 5.37%
NKTR Nektar Therapeutics Buy 9.09% -2.76%
NUTX Nutex Health Inc. Buy 9.36% -4.88%
CDMO Avid Bioservices, Inc. Buy 8.56% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • CDMO
Assets Removed
Asset Action Perf %
CDXS Sell All -9.73%
Assets Rebalanced
None
2024-10-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 9.24% -4.23%
ORGO Organogenesis Holdings Inc. Buy 9.71% 0.65%
ARDX Ardelyx, Inc. Buy 9.16% -4.3%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.08% 5.27%
VCEL Vericel Corporation Buy 9.52% -0.62%
CDXS Codexis, Inc. Buy 9.32% -2.65%
SGMO Sangamo Therapeutics, Inc. Buy 11.94% 24.74%
VREX Varex Imaging Corporation Buy 9.76% 3.64%
NKTR Nektar Therapeutics Buy 9.36% -0.69%
NUTX Nutex Health Inc. Buy 9.91% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NUTX
Assets Removed
None
Assets Rebalanced
None
2024-10-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 9.77% -1.64%
ORGO Organogenesis Holdings Inc. Buy 10.03% 0.97%
ARDX Ardelyx, Inc. Buy 9.6% -2.65%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.44% 5.84%
VCEL Vericel Corporation Buy 9.65% -2.16%
CDXS Codexis, Inc. Buy 9.57% -2.95%
SGMO Sangamo Therapeutics, Inc. Buy 9.25% -6.19%
VREX Varex Imaging Corporation Buy 10.11% 4.13%
NKTR Nektar Therapeutics Buy 9.3% -4.14%
The percentage of cash held in the portfolio is: 12.27%
New Assets Added
None
Assets Removed
Asset Action Perf %
BKD Sell All 3.8%
Assets Rebalanced
None
2024-10-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 10.2% 4.23%
ORGO Organogenesis Holdings Inc. Buy 9.76% -0.32%
ARDX Ardelyx, Inc. Buy 9.38% -3.48%
BKD Brookdale Senior Living Inc. Buy 10.62% 9.26%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.46% 7.64%
VCEL Vericel Corporation Buy 9.39% -3.37%
CDXS Codexis, Inc. Buy 9.65% -0.59%
SGMO Sangamo Therapeutics, Inc. Buy 9.41% -3.09%
VREX Varex Imaging Corporation Buy 9.56% 0%
NKTR Nektar Therapeutics Buy 9.56% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • VREX
  • NKTR
Assets Removed
Asset Action Perf %
RDNT Sell All -3.2%
Assets Rebalanced
None
2024-10-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 10.07% 3.05%
ORGO Organogenesis Holdings Inc. Buy 10.16% 3.9%
ARDX Ardelyx, Inc. Buy 9.59% -1.16%
BKD Brookdale Senior Living Inc. Buy 9.73% 0.33%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 9.96% 2.69%
VCEL Vericel Corporation Buy 9.67% -0.33%
RDNT RadNet, Inc. Buy 9.72% 0.2%
CDXS Codexis, Inc. Buy 9.7% 0%
SGMO Sangamo Therapeutics, Inc. Buy 9.7% 0%
The percentage of cash held in the portfolio is: 11.7%
New Assets Added
  • CDXS
  • SGMO
Assets Removed
None
Assets Rebalanced
None
2024-10-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 9.93% 0.7%
ORGO Organogenesis Holdings Inc. Buy 9.89% 0.32%
ARDX Ardelyx, Inc. Buy 9.7% -0.83%
BKD Brookdale Senior Living Inc. Buy 9.78% 0%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 9.78% 0%
VCEL Vericel Corporation Buy 9.78% 0%
RDNT RadNet, Inc. Buy 9.78% 0%
The percentage of cash held in the portfolio is: 31.35%
New Assets Added
  • BKD
  • ARWR
  • VCEL
  • RDNT
Assets Removed
None
Assets Rebalanced
None
2024-10-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 9.86% 0%
ORGO Organogenesis Holdings Inc. Buy 9.83% -0.32%
ARDX Ardelyx, Inc. Buy 9.79% 0%
The percentage of cash held in the portfolio is: 70.52%
New Assets Added
  • ARDX
Assets Removed
None
Assets Rebalanced
None
2024-10-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 9.77% -1.17%
ORGO Organogenesis Holdings Inc. Buy 9.7% -1.95%
The percentage of cash held in the portfolio is: 80.53%
New Assets Added
None
Assets Removed
Asset Action Perf %
BCRX Sell All -6.07%
Assets Rebalanced
None
2024-10-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 9.88% 0.94%
BCRX BioCryst Pharmaceuticals, Inc. Buy 9.79% 0%
ORGO Organogenesis Holdings Inc. Buy 9.79% 0%
The percentage of cash held in the portfolio is: 70.54%
New Assets Added
  • BCRX
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-10-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 90.2%
New Assets Added
  • IRWD
Assets Removed
None
Assets Rebalanced
None
2024-09-30 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
PODD Sell All 13.51%
Assets Rebalanced
None
2024-09-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 12.46% 16.82%
The percentage of cash held in the portfolio is: 87.54%
New Assets Added
None
Assets Removed
Asset Action Perf %
AADI Sell All 8.57%
NVCR Sell All -11.63%
Assets Rebalanced
None
2024-09-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 10.61% 8%
PODD Insulet Corporation Buy 12.45% 16.92%
NVCR NovoCure Limited Buy 8.26% -8.98%
The percentage of cash held in the portfolio is: 68.68%
New Assets Added
None
Assets Removed
Asset Action Perf %
MYGN Sell All -1.56%
Assets Rebalanced
None
2024-09-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 10.69% 9.14%
PODD Insulet Corporation Buy 12.41% 16.9%
NVCR NovoCure Limited Buy 8.29% -8.42%
MYGN Myriad Genetics, Inc. Buy 8.56% -0.15%
The percentage of cash held in the portfolio is: 60.05%
New Assets Added
None
Assets Removed
Asset Action Perf %
ESPR Sell All -10.93%
Assets Rebalanced
None
2024-09-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 10.7% 10.29%
PODD Insulet Corporation Buy 12.17% 15.73%
ESPR Esperion Therapeutics, Inc. Buy 8.49% -8.2%
NVCR NovoCure Limited Buy 8.67% -3.32%
MYGN Myriad Genetics, Inc. Buy 8.7% 2.48%
The percentage of cash held in the portfolio is: 51.26%
New Assets Added
None
Assets Removed
Asset Action Perf %
AGEN Sell All 6.76%
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings